STRS Ohio’s Orgenesis Inc. Common Stock ORGS Stock Holding History

STRS Ohio’s Portfolio ORGS Stock Details ORGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-460	Closed	-$23K	–	2306
2020 Q3	$23K	Hold	460	–	–	﹤0.01%	2075
2020 Q2	$27K	Buy	+460	New	+$27.8K	﹤0.01%	2011

Other funds holding ORGS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

STRS Ohio's ORGS Position: Q4 2020 in Review

STRS Ohio sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2020, closing a stake of 460 shares — an estimated $23K sold.

STRS Ohio first reported a position in ORGS in Q2 2020 and held it in 2 quarters. The position peaked at $27K in Q2 2020. 37 funds tracked by Wall St. Rank hold ORGS as of Q4 2020.

STRS Ohio reported no remaining Orgenesis Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
STRS Ohio sold 460 Orgenesis Inc. Common Stock shares in Q4 2020, an estimated $23K.
STRS Ohio first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 2 quarters.
STRS Ohio's Orgenesis Inc. Common Stock position peaked at $27K in Q2 2020.
37 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.